Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stadler

Showing results (551-560 of 724) with videos related to

Pageof 73
Sort By:
Clinical Genitourinary Cancer|January 16, 2024
Bladder-Preserving Trimodality Therapy With CapecitabineConnor Lynch, Randy F Sweis, Parth Modi, et al.
Molecular Immunology|March 3, 2006
Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5aBrigitte Hantusch, Regina Knittelfelder, Julia Wallmann, et al.
In Vivo (Athens, Greece)|May 12, 1998
Prostate cancer metastasis-suppressor genes: a current perspectiveB A Yoshida, M A Chekmareva, J F Wharam, et al.
European Biophysics Journal : EBJ|February 25, 2009
Hemoglobin senses body temperatureG M Artmann, Ilya Digel, K F Zerlin, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 28, 2006
Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate)M Stadler, G Gruber, C Kannicht, et al.
Immunology Letters|February 17, 2007
Allergen motifs and the prediction of allergenicityPamela Marti, Renato Truffer, Michael B Stadler, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2007
A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinomaWalter M Stadler, Apurva A Desai, David I Quinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic diseaseJoseph K Salama, Steven J Chmura, Neil Mehta, et al.
Clinical Genitourinary Cancer|October 19, 2015
A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate CancerMark N Stein, Maha Hussain, Walter M Stadler, et al.
Clinical Genitourinary Cancer|September 17, 2016
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal CarcinomaRandy F Sweis, Milica Medved, Shannon Towey, et al.
Pageof 73

Showing results (551-560 of 724) with videos related to

Sort By:
Pageof 73
Clinical Genitourinary Cancer|January 16, 2024
Bladder-Preserving Trimodality Therapy With CapecitabineConnor Lynch, Randy F Sweis, Parth Modi, et al.
Molecular Immunology|March 3, 2006
Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5aBrigitte Hantusch, Regina Knittelfelder, Julia Wallmann, et al.
In Vivo (Athens, Greece)|May 12, 1998
Prostate cancer metastasis-suppressor genes: a current perspectiveB A Yoshida, M A Chekmareva, J F Wharam, et al.
European Biophysics Journal : EBJ|February 25, 2009
Hemoglobin senses body temperatureG M Artmann, Ilya Digel, K F Zerlin, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 28, 2006
Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate)M Stadler, G Gruber, C Kannicht, et al.
Immunology Letters|February 17, 2007
Allergen motifs and the prediction of allergenicityPamela Marti, Renato Truffer, Michael B Stadler, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2007
A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinomaWalter M Stadler, Apurva A Desai, David I Quinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic diseaseJoseph K Salama, Steven J Chmura, Neil Mehta, et al.
Clinical Genitourinary Cancer|October 19, 2015
A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate CancerMark N Stein, Maha Hussain, Walter M Stadler, et al.
Clinical Genitourinary Cancer|September 17, 2016
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal CarcinomaRandy F Sweis, Milica Medved, Shannon Towey, et al.
Pageof 73